| 1 | Technology | XLK | +28.1% |
| 2 | Energy | XLE | +26.1% |
| 3 | Materials | XLB | +13.1% |
| 4 | Real Estate | XLRE | +12.3% |
| 5 | Industrials | XLI | +11.5% |
| 6 | Consumer Staples | XLP | +10.5% |
| 7 | Utilities | XLU | +3.1% |
| 8 | Healthcare | XLV | -1.1% |
| 9 | Consumer Disc. | XLY | -1.5% |
| 10 | Financials | XLF | -2.9% |
| 11 | Communication | XLC | -4.5% |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q1 '26 | 5/6/26 | $-4.04 | $-3.25 | +19.6% | -25% | $0.3B | $0.3B | +3.4% | +127% |
| Q4 '25 | 2/19/26 | $-0.52 | $-2.57 | -3.9% | +5% | $0.3B | $0.3B | +2.6% | +211% |
| Q3 '25 | 11/4/25 | $-1.99 | $-5.08 | -1.6% | -3% | $0.2B | $0.3B | +16.2% | +362% |
| Q2 '25 | 8/5/25 | $-3.52 | $-1.90 | +46.0% | +73% | $0.2B | $0.2B | +31.9% | +1354% |
| Q1 '25 | 5/1/25 | $-3.79 | $-3.32 | +12.4% | +55% | $0.1B | $0.1B | +20.2% | — |